Sana Biotechnology, Inc. is a cutting-edge biotechnology company pioneering the development of engineered cells as medicines. The company’s mission is to repair and control human biology by replacing, repairing, or controlling damaged cells within the body.
Unlike traditional therapies that treat disease symptoms, Sana focuses on replacing or reprogramming the underlying cellular mechanisms. Its platforms combine cell engineering, stem cell biology, and advanced gene-delivery technologies to develop next-generation treatments for a range of serious diseases, including type 1 diabetes, autoimmune disorders, and cancers.
Unlike traditional therapies that treat disease symptoms, Sana focuses on replacing or reprogramming the underlying cellular mechanisms. Its platforms combine cell engineering, stem cell biology, and advanced gene-delivery technologies to develop next-generation treatments for a range of serious diseases, including type 1 diabetes, autoimmune disorders, and cancers.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.